Effect of mechanical circulatory support on outcomes after heart transplantation

被引:36
作者
Drakos, SG [1 ]
Kfoury, AG [1 ]
Long, JW [1 ]
Stringham, JC [1 ]
Gilbert, EM [1 ]
Moore, SA [1 ]
Campbell, BK [1 ]
Nelson, KE [1 ]
Horne, BD [1 ]
Renlund, DG [1 ]
机构
[1] Utah Transplantat Affiliate Hosp, Cardiac Transplant Program, Salt Lake City, UT USA
关键词
D O I
10.1016/j.healun.2005.07.014
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Mechanical circulatory support (MCS) before heart transplantation was previously associated with worse post-transplant outcomes than when MCS was not required. Given the changes in technology, expertise, patient selection, and timing of subsequent transplantation, we hypothesized that patients who require MCS before heart transplantation have similar outcomes after transplantation as those not requiring pre-transplant MCS. Methods: We retrospectively reviewed 278 patients who underwent cardiac transplantation from 1993 to 2002. MCS was required in 72 patients (HeartMate LVAS in 66, CardioWest Total Artificial Heart in 6) and was not required in 206 patients. The influence of pre-transplant MCS on post-transplant outcomes was assessed in the 2 groups. Results: Baseline clinical characteristics (age, gender, etiology of heart failure, history of diabetes mellitus, and donor age and gender) were similar in the 2 groups. One-month and I-year survival after transplantation did not differ between the groups (MCS, 92% and 85%, respectively vs; no MCS, 97% and 92%, respectively). Similar proportions of patients were free from rejection (International Society for Heart and Lung Transplantation score >= 3A) at 1 year of follow-up (MCS, 56% vs no MCS, 52%, p = 0.60). No difference was observed between MCS and no MCS patients in other post-transplant events such as hospital stay, intensive care unit stay, extubation time, acute allograft dysfunction, reoperation rates, acute renal dysfunction, acute hepatic dysfunction, infections, arrhythmias, thromboembolic complications, neurologic complications, gastrointestinal complications and the development of cardiac allograft vasculopathy. The incidence of chronic renal insufficiency was actually lower in the MCS Group (15.3% vs 37.9%, p = .001). Conclusion:. Post-transplant outcomes after pre-transplant use of MCS are similar to those when MCS is not required. J Heart Lung Transplant 2006;25:22-8. Copyright (c) 2006 by the International Society for Heart and Lung Transplantation.
引用
收藏
页码:22 / 28
页数:7
相关论文
共 22 条
[1]  
Boltwood CM, 2004, NEW ENGL J MED, V351, P2552
[2]   A RELIABLE BRIDGE TO CARDIAC TRANSPLANTATION - THE TCI LEFT-VENTRICULAR ASSIST DEVICE [J].
BURTON, NA ;
LEFRAK, EA ;
MACMANUS, Q ;
HILL, A ;
MARINO, JA ;
SPEIR, AM ;
AKL, BF ;
ALBUS, RA ;
MASSIMIANO, PS .
ANNALS OF THORACIC SURGERY, 1993, 55 (06) :1425-1431
[3]  
Copeland JG, 2004, NEW ENGL J MED, V351, P2552
[4]   Cardiac replacement with a total artificial heart as a bridge to transplantation [J].
Copeland, JG ;
Smith, RG ;
Arabia, FA ;
Nolan, PE ;
Sethi, GK ;
Tsau, PH ;
McClellan, D ;
Slepian, MJ ;
Foy, B ;
Long, J ;
Doty, D ;
Tector, A ;
Kormos, R .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (09) :859-867
[5]   Mechanical Circulatory Support device database of the International Society for Heart and Lung Transplantation: Second Annual Report-2004 [J].
Deng, MC ;
Edwards, LB ;
Hertz, MI ;
Rowe, AW ;
Keck, BM ;
Kormos, R ;
Naftel, DC ;
Kirklin, JK .
JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2004, 23 (09) :1027-1034
[6]   Implantable left ventricular assist devices provide an excellent outpatient bridge to transplantation and recovery [J].
DeRose, JJ ;
Umana, JP ;
Argenziano, M ;
Catanese, KA ;
Gardocki, MT ;
Flannery, M ;
Levin, HR ;
Sun, BC ;
Rose, EA ;
Oz, MC .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1997, 30 (07) :1773-1777
[7]   Multicenter clinical evaluation of the HeartMate vented electric left ventricular assist system in patients awaiting heart transplantation [J].
Frazier, OH ;
Rose, EA ;
Oz, MC ;
Dembitsky, W ;
McCarthy, P ;
Radovancevic, B ;
Poirier, VL ;
Dasse, KA .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2001, 122 (06) :1186-1195
[8]   IMPROVED MORTALITY AND REHABILITATION OF TRANSPLANT CANDIDATES TREATED WITH A LONG-TERM IMPLANTABLE LEFT-VENTRICULAR ASSIST SYSTEM [J].
FRAZIER, OH ;
ROSE, EA ;
MCCARTHY, P ;
BURTON, NA ;
TECTOR, A ;
LEVIN, H ;
KAYNE, HL ;
POIRIER, VL ;
DASSE, KA .
ANNALS OF SURGERY, 1995, 222 (03) :327-338
[9]   The Registry of the International Society for Heart and Lung Transplantation: Seventeenth official report - 2000 [J].
Hosenpud, JD ;
Bennett, LE ;
Keck, BM ;
Boucek, MM ;
Novick, RJ .
JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2000, 19 (10) :909-931
[10]   Preformed IgG antibodies against major histocompatibility complex class II antigens are major risk factors for high-grade cellular rejection in recipients of heart transplantation [J].
Itescu, S ;
Tung, TC ;
Burke, EM ;
Weinberg, A ;
Moazami, N ;
Artrip, JH ;
Suciu-Foca, N ;
Rose, EA ;
Oz, MC ;
Michler, RE .
CIRCULATION, 1998, 98 (08) :786-793